Skip navigation

Zastosuj identyfikator do podlinkowania lub zacytowania tej pozycji: http://hdl.handle.net/20.500.12128/20421
Tytuł: Lipophilicity, pharmacokinetic properties, and molecular docking study on SARS-CoV-2 target for betulin triazole derivatives with attached 1,4- quinone
Autor: Kadela-Tomanek, Monika
Jastrzębska, Maria
Marciniec, Krzysztof
Chrobak, Elwira
Bębenek, Ewa
Boryczka, Stanisław
Słowa kluczowe: 1,4-quinone; betulin; lipophilicity; molecular docking; SARS-CoV-2 proteins
Data wydania: 2021
Źródło: "Pharmaceutics" (2021), iss. 6, art. no. 781, s. 1-21
Abstrakt: A key parameter in the design of new active compounds is lipophilicity, which influences the solubility and permeability through membranes. Lipophilicity affects the pharmacodynamic and toxicological profiles of compounds. These parameters can be determined experimentally or by using different calculation methods. The aim of the research was to determine the lipophilicity of betulin triazole derivatives with attached 1,4-quinone using thin layer chromatography in a reverse phase system and a computer program to calculate its theoretical model. The physiochemical and pharmacokinetic properties were also determined by computer programs. For all obtained parameters, the similarity analysis and multilinear regression were determined. The analyses showed that there is a relationship between structure and properties under study. The molecular docking study showed that betulin triazole derivatives with attached 1,4-quinone could inhibit selected SARS-CoV-2 proteins. The MLR regression showed that there is a correlation between affinity scoring values (DG) and the physicochemical properties of the tested compounds.
URI: http://hdl.handle.net/20.500.12128/20421
DOI: 10.3390/pharmaceutics13060781
ISSN: 1999-4923
Pojawia się w kolekcji:Artykuły (WNŚiT)

Pliki tej pozycji:
Plik Opis RozmiarFormat 
Jastrzebska_lipophilicity_pharmacokinetic_property.pdf3,55 MBAdobe PDFPrzejrzyj / Otwórz
Pokaż pełny rekord


Uznanie Autorstwa 3.0 Polska Creative Commons Creative Commons